Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Adjusting to change in healthcare: Learning from translational research

White Papers and Resources | March 30, 2016 | Blue Latitude Health

In this article, Blue Latitude Health's Head of Insight, Martine Leroy, explores how pharma could learn from translational research organisations in adapting their approach to the changing healthcare landscape.

There’s never a dull moment at Lucid Group

Press Releases | March 22, 2016 | Lucid Group Communications Limited

Andrea Hamlin, Angela Tye-Galichet, Emma Herring and Ify Onyeaso were all treated to a fabulous lunch with the Lucid Co-Founders, Dennis O’Brien and Jan Steele in celebration of their 5...

Lucid Group support local charity event

Press Releases | March 22, 2016 | Lucid Group Communications Limited

Lucid Group donated 75 Easter chocolate bunnies to a group of local school children organising an Easter Egg Hunt who were raising funds for Médecins Sans Frontières. The egg hunt...

Why everyone is standing-up to the sitting-down problem

White Papers and Resources | March 21, 2016 | Say Communications

Are the exercise gurus really onto something? Find out how workplace fitness can boost your health and reduce your bum, while helping you become more productive throughout the day.

What we do and who we do it for | Pegasus

Videos and Podcasts | March 18, 2016 | Inizio

We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital...

Understanding decision making in health | Pegasus

Videos and Podcasts | March 18, 2016 | Inizio

To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

An animated approach to communicating healthy messages | Pegasus

Videos and Podcasts | March 18, 2016 | Inizio

Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...

Focus on multiple myeloma treatment: Witnessing a transformation

White Papers and Resources | March 15, 2016 | Blue Latitude Health

Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.

The ROI of user experience in pharma and healthcare: How to engage your customers

White Papers and Resources | March 14, 2016 | Blue Latitude Health

In this article, Head of Customer Experience Elisa del Galdo of Blue Latitude Health breaks down how to understand the return on investment of user experience in pharma and healthcare.

Why health psychology should inform pharma strategy

Press Releases | March 10, 2016 | Lucid Group Communications Limited

In the March 2016 edition of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) discusses why pharma should look to health psychology and adopt a behaviour-change strategy to inform...